Participations in affiliated and associated companies
of
Fresenius SE & Co. KGaA
Bad Homburg v.d.H.
As at December 31st 2021
Fresenius SE & Co. KGaA Else-Kröner-Straße 1 61352 Bad Homburg v.d.H.
Content | Page |
1. Affiliated domestic companies | |
1.1 Fresenius Corporate | 1 |
1.2 Fresenius Medical Care | 3 |
1.3 Fresenius Kabi | 9 |
1.4 Fresenius VAMED | 10 |
1.5 Fresenius HELIOS | 17 |
2. Affiliated consolidated foreign companies | |
2.1Fresenius Corporate | 38 |
2.2Fresenius Medical Care | 39 |
2.3Fresenius Kabi | 215 |
2.4Fresenius VAMED | 223 |
2.5Fresenius HELIOS | 228 |
3. Affiliated non consolidated foreign companies | |
3.1Fresenius Corporate | 236 |
3.2Fresenius Medical Care | 237 |
3.3Fresenius Kabi | 238 |
3.4Fresenius VAMED | 239 |
3.5Fresenius HELIOS | - |
4. Associated companies | |
4.1Fresenius Corporate | - |
4.2Fresenius Medical Care | 243 |
4.3Fresenius Kabi | 250 |
4.4Fresenius VAMED | 251 |
4.5Fresenius HELIOS | 255 |
Agenda
- = No annual financial statement available
- = Value as of March 31 of the reporting period
- = Value as of June 30 of the reporting period
- = Value as of September 30 of the reporting period
- = No actual data of equity or net profit/loss of the reporting
period HBI, but IFRS-closing (excluding minority interests) on level of HELIOS Kliniken GmbH
- = No actual data of equity or net profit/loss of the reporting
period HBI, but IFRS closing on level of FMC Holdings Inc.
- = No actual data of the reporting available
- = These companies make use of exemption rule § 264 b HGB
- = These companies make use of exemption rule § 264 (3) HGB
- = Value as of December 31 of the preceding reporting period
k = Consolidated value for subgroup Fresenius Kabi Pharmaceuticals Holding, Inc.
- = No actual data of equity or net profit/loss for the reporting
period, but closing on level of Fresenius Kabi Pharmaceuticals Holding, Inc.
- = The information of the federal state do not refer to the city of
the registered seat.
- = Consolidated value for subgroup Fresenius Kabi Argentina S.A.
- = No actual data of equity or net profit/loss for the reporting
period, but closing on level of Fresenius Kabi Argentina S.A.
- = Consolidated value for subgroup Fresenius Kabi Italia S.p.A.
- = No actual data of equity or net profit/loss for the reporting
period, but closing on level of Fresenius Kabi Italia S.p.A.
- = Consolidated value for subgroup FHC (Holdings) Ltd.
- = No actual data of equity or net profit/loss for the reporting
period, but closing on level of FHC (Holdings) Ltd.
- = These companies are consolidated due to contractual arrangements.
- = No actual data of equity or net profit/loss of the reoporting period HBI, but IFRS-closing (excluding minority interests) on
level of HELIOS Healthcare Spain S.L.U.
- = This company is consolidated due to the majority of the voting rights
- = Value as of July 31 of the reporting period
- = No actual data of equity or net profit/loss of the reporting period HBI, but IFRS-closing (excluding minority interests) on level of HELIOS Fertility Spain S.L.U.
FRESENIUS SE & Co. KGaA, Bad Homburg v. d. H.
List of affiliated and associated companies as of December 31st, 2021
Domestic affiliated companies of business segment Fresenius Corporate
Direct and | Equity | Net profit/loss | |||
No. | Company | indirect | 31.12.2021 | 2021 | |
interest | converted at | converted at | |||
spot rate at | spot rate at | ||||
bal. sheet date | bal. sheet date | ||||
% | KEUR | KEUR | |||
Consolidated financial statements - with profit & loss transfer agreement | |||||
1 | Fresenius Digital Technology GmbH | (i) | 100 | 7.221 | 0 |
Bad Homburg v. d. H. | |||||
Germany | |||||
(indirect interest through no. | 13 ) | ||||
2 | Fresenius Kabi AG | (i) | 100 | 2.519.495 | 151.053 |
Bad Homburg v. d. H. | |||||
Germany | |||||
3 | Fresenius ProServe GmbH | (i) | 100 | 5.115.387 | 0 |
Bad Homburg v. d. H. | |||||
Germany | |||||
Consolidated financial statements - without profit & loss transfer agreement | |||||
4 | FPS Immobilien Verwaltungs GmbH | 100 | 28 | 0 | |
Bad Homburg v. d. H. | |||||
Germany | |||||
(indirect interest through no. | 3 ) | ||||
5 | FPS Immobilien Verwaltungs GmbH & Co. Reichenbach KG | (h) | 100 | 100 | 83 |
Bad Homburg v. d. H. | |||||
Germany | |||||
(indirect interest through no. | 3 ) | ||||
6 | Fresenius Immobilien-Verwaltungs-GmbH | 100 | 73 | 2 | |
Bad Homburg v. d. H. | |||||
Germany | |||||
7 | Fresenius Immobilien-Verwaltungs-GmbH & Co. Objekt Friedberg | (h) | 100 | 5.817 | 72 |
KG | |||||
Bad Homburg v. d. H. | |||||
Germany | |||||
8 | Fresenius Immobilien-Verwaltungs-GmbH & Co. Objekt | (h) | 100 | 6.941 | 3.363 |
Schweinfurt KG | |||||
Bad Homburg v. d. H. | |||||
Germany | |||||
9 | Fresenius Immobilien-Verwaltungs-GmbH & Co. Objekt St. | (h) | 100 | 11.248 | 6.208 |
Wendel KG | |||||
Bad Homburg v. d. H. | |||||
Germany | |||||
10 | Fresenius Medical Care AG & Co. KGaA | 32 | 4.885.365 | 1.737.017 | |
Hof/Saale | |||||
Germany | |||||
11 | Fresenius Medical Care Management AG | 100 | 4.617 | 201 | |
Hof a. d. Saale | |||||
Germany | |||||
12 | ProServe Krankenhaus Beteiligungsgesellschaft mbH & Co. KG | (h) | 100 | 12.272 | 612 |
Baierbrunn | |||||
Germany | |||||
(indirect interest through no. | 3 ) |
1
Domestic affiliated companies of business segment Fresenius Corporate
Direct and | Equity | Net profit/loss | ||
No. | Company | indirect | 31.12.2021 | 2021 |
interest | converted at | converted at | ||
spot rate at | spot rate at | |||
bal. sheet date | bal. sheet date | |||
% | KEUR | KEUR | ||
Not consolidated financial statements - with profit & loss transfer agreement | ||||
13 Fresenius Versicherungsvermittlungs GmbH | 100 | 7.585 | 0 | |
Bad Homburg v. d. H. | ||||
Germany | ||||
14 Hyginus Publisher GmbH | 100 | 26 | 0 | |
Bad Homburg v. d. H. | ||||
Germany | ||||
Not consolidated financial statements - without profit & loss transfer agreement | ||||
15 Fresenius Hochschulstiftung für Gesundheitsmanagement | 100 | 25 | 0 | |
gemeinnützige GmbH | ||||
Bad Homburg v. d. H. | ||||
Germany | ||||
16 hospitalia activHealth gmbh | 100 | -7.400 | -51 | |
Oberursel | ||||
Germany | ||||
(indirect interest through no. | 3 ) |
2
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Fresenius SE & Co. KGaA published this content on 24 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 March 2022 16:11:04 UTC.